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Abstract
Context: Telomeres are biomarkers of biological aging. Shorter telomeres have been associated with increased adiposity in
adults. However, this relationship remains unclear in children and adolescents.
Objective: To evaluate the association between telomere length (TL) and adiposity markers in overweight/obese
adolescents after an intensive program. We hypothesize that greater TL at baseline would predict a better response to a
weight loss treatment.
Design, Setting, Patients and Intervention: The EVASYON is a multidisciplinary treatment program for adolescents with
overweight and obesity that is aimed at applying the intervention to all possibly involved areas of the individual, such as
dietary habits, physical activity and cognitive and psychological profiles. Seventy-four participants (36 males, 38 females,
12–16 yr) were enrolled in the intervention program: 2 months of an energy-restricted diet and a follow-up period (6
months).
Main Outcome: TL was measured by quantitative real-time polymerase chain reaction at baseline and after 2 months;
meanwhile, anthropometric variables were also assessed after 6 months of follow-up.
Results: TL lengthened in participants during the intensive period (+1.961.0, p,0.001) being greater in overweight/obese
adolescents with the shortest telomeres at baseline (r =20.962, p,0.001). Multivariable linear regression analysis showed
that higher baseline TL significantly predicted a higher decrease in body weight (B =21.53, p = 0.005; B =22.25, p = 0.047)
and in standard deviation score for body mass index (BMI-SDS) (B =20.22, p = 0.010; B =20.47, p = 0.005) after the intensive
and extensive period treatment respectively, in boys.
Conclusion: Our study shows that a weight loss intervention is accompanied by a significant increase in TL in overweight/
obese adolescents. Moreover, we suggest that initial longer TL could be a potential predictor for a better weight loss
response.
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Introduction
Telomeres are tandem TTAGGG repeats of DNA that,
together with associated protein factors, cap the ends of
chromosomes and promote chromosome stability [1]. For
individuals at any age, telomere length (TL) depends on, first,
the initial setting of TL in the newborn, and second, the
magnitude of telomere erosion from birth onwards [2]. Telomere
attrition, in turn, depends on cell replication rate, cumulative
exposure to agents that produce DNA damage (such as oxidative,
inflammatory, endocrine and other forms of biological stress), and
activity of the telomerase enzyme [3].
The prevalence of obesity is increasing rapidly worldwide, with
a high impact on children and adolescents [4]. Therefore, treating
obesity in young people is critical to prevent adult obesity-related
complications [5]. It is well known that obesity is characterized as
a state of chronic inflammation and heightened oxidative stress
[6,7]. However, existing data on the relationship between obesity
and TL in adults have yielded equivocal results; several studies
reported an inverse association of TL with obesity [8–11], but
others did not [12,13]. Differing outcomes have also been found in
pediatric population. Zannolli et al. [14] found no difference in TL
between obese and normal-weight Caucasian children, whereas
Al-Attas et al. [15] and Buxton et al. [16] reported significantly
shorter TL in obese children compared with the nonobese ones.
There is just one study regarding the relationship between
adiposity and TL in adolescents that showed no association, but
it demonstrated that race and sex differences in TL have already
emerged during adolescence [17].
To date, a limited number of studies have explored the
association between TL and adiposity indices after a lifestyle
intervention, suggesting that maintaining or losing weight can lead
to preservation or lengthening of the TL [10,11,18,19]. Moreover,
only two prospective studies considered TL as a biomarker for
adiposity changes in an elderly population [9,11].
To our knowledge, no prospective studies have assessed the
relationship between TL and changes in adiposity traits in children
or adolescents following a lifestyle educational program. Thus, the
aim of this study was to assess the relationship between baseline
TL and changes in anthropometric and obesity parameters after 2
and 6 months of a multidisciplinary intervention in overweight/
obese adolescents. We hypothesize that greater TL at baseline
would predict a better response to the multidisciplinary interven-
tion, as has been previously observed in adult studies [11].
Subjects and Methods
Ethics Statement
Written consent to participate was requested from both parents
and adolescents. The study protocols were performed in accor-
dance with the ethical standards laid down in the 1961
Declaration of Helsinki (as revised in South Korea in 2008),
following the European Economic Community (EEC) Good
Clinical Practice guidelines (document 111/3976/88 of July
1990) and current Spanish law, which regulates clinical research
in humans (Royal Decree 561/1993 regarding clinical trials). The
study protocol was approved by the institutional review board and
the Ethics Committee of each hospital that participated in this
project (Madrid, Granada, Pamplona, Zaragoza, Santander) and
by the Ethics Committee of the Spanish Council for Scientific
Research (CSIC).
Study Population and Intervention
The study population included 204 overweight or obese
adolescents within the EVASYON program; Development,
Implementation, and Evaluation of the Efficacy of a Therapeutic
Program for Adolescents with Overweight and Obesity: Integral
Education on Nutrition and Physical Activity (EVASYON) study
(http://www.estudioevasyon.com/). EVASYON study was car-
ried out in 5 Spanish cities (Granada, Madrid, Pamplona,
Santander, and Zaragoza) and it is a lifestyle education program
supported by a multidisciplinary team of nutritionists, physical
education specialists, psychologists, and pediatricians. The study
was implemented in two stages: an intensive, energy-restricted
period for the first 2 months, and an extensive body-weight follow-
up period for the last 11 months.
In the present study, we present data from the intensive
treatment period corresponding to the first 2 months (an energy-
restricted phase) and 6 months regarding the extensive interven-
tion, in a subsample of 74 participants (49% males) from whom
Table 1. Anthropometric measures of the overweight/obese adolescents at baseline and during the weight loss treatment,
stratifying by sex.
BOYS GIRLS
Baseline 2 months 6 months P-value1 Baseline 2 months 6 months P-value1 P-value2
n 36 38
Age 14.3 (0.9) 14.4 (1.1) 0.512
Weight (kg) 85.9 (15.2) 81.2 (14.4) 78.4 (13.6) ,0.001 84.3 (14.9) 80.6 (13.7) 81.1 (13.5) ,0.001 0.650
BMI-SDS 5.0 (1.6) 4.1 (1.7) 3.2 (1.6) ,0.001 4.6 (2.0) 3.9 (1.7) 3.9 (1.9) ,0.001 0.363
Body fat (%) 47.3 (8.5) 42.8 (8.1) 39.2 (8.4) ,0.001 44.1 (6.4) 40.1 (6.7) 40.3 (5.5) ,0.001 0.082
Waist circumference (cm) 101.9 (9.8) 98.5 (10.6) 92.0 (10.1) ,0.001 108.4 (12.0) 104.3 (10.6) 102.6 (12.4) ,0.001 0.014
Hip circumference (cm) 101.6 (22.8) 99.0 (20.8) 95.1 (19.6) ,0.001 85.9 (27.4) 81.5 (23.9) 81.8 (22.9) 0.133 0.011
Waist to hip ratio 1.08 (0.38) 1.06 (0.36) 1.03 (0.35) 0.087 1.39 (0.46) 1.39 (0.42) 1.36 (0.43) 0.695 0.002
Waist to height ratio 0.61 (0.05) 0.59 (0.06) 0.54 (0.05) ,0.001 0.67 (0.07) 0.64 (0.06) 0.63 (0.08) ,0.001 ,0.001
S 6 skinfolds (mm) 182.9 (24.9) 166.5 (28.8) 150.2 (37.0) ,0.001 194.6 (27.6) 179.3 (28.3) 176.9 (31.5) ,0.001 0.113
The table shows means (SD). BMI-SDS: Standard Deviation Score for BMI.
1: p value in three different time points analyzed by repeated-measures ANOVA in subjects distributed by sex.
2: p value for the comparison at baseline between boys and girls.
doi:10.1371/journal.pone.0089828.t001
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DNA samples were available. We could not do the analysis at 12
months of follow-up due to the observed drop-out rate (26%). 36
males (2.8% were overweight and 97.2% obese) and 38 females
(5.3% overweight and 94.7% obese) were enrolled. The study
included 12- to 16-year-old overweight or obese adolescents,
according to Cole’s criteria [20], who were brought up in Spain
(inclusion criteria), had no diagnosed disease associated with
obesity, were not receiving pharmacologic treatment and were not
diagnosed of anorexia, bulimia or other eating disorders (exclusion
criteria). Cole et al. [20] developed an internationally acceptable
definition of child overweight and obesity, specifying the
measurement, the reference population, and the age and sex
specific cut off points. They obtained the reference population by
averaging across a heterogeneous mix of surveys from different
countries, with widely differing prevalence rates for obesity,
whereas the appropriate cut off point was defined in body mass
index (BMI) units in young adulthood and extrapolated to
childhood, conserving the corresponding centile in each dataset.
Based on food intake questionnaires, a personalized diet (30% of
energy (E) from fat, 15% E from proteins, and 55% E from
carbohydrates) [21] was prescribed while the physical activity
program was instructed to each adolescent. During the intensive
program period, the adolescents attended weekly group sessions
where they received nutritional education, dietary advice, physical
activity recommendation, as well as psychological support. During
the extensive body-weight maintenance period, adolescents
attended monthly in person follow-up visits with the registered
dietician. The participants and their families received group
sessions on different aspects such as diet, physical activity, healthy
habits and weight maintenance skills, how to engage in healthy
weight control behaviors and relapse prevention. The description
of the complete EVASYON study has been previously published
elsewhere [22,23].
Weight and height were measured with an electronic scale
(Type SECA 861; SECA, Hamburg, Germany) and with a
telescopic height measuring instrument (Type SECA 225),
respectively. BMI was calculated as weight (kg)/height2 (m2),
then, individual BMI values were converted into SDS using age
and specific cut-points according to the Spanish children and
adolescent growth references [24]. Skinfolds were measured on the
left side of the body to the nearest 0.1 mm with a skinfold caliper
(Caliper Holtain; Holtain Ltd., Walles, UK) at triceps, biceps,
subscapular, suprailiac, thigh, and calf. The waist and hip
circumferences were measured with a flexible non-stretchable
measuring tape (Type SECA 200). Fat mass percentage was
calculated according to the Slaughter formula [25].
Telomere Length Assessment
TL was measured in genomic DNA extracted from human
peripheral blood samples, using a real-time quantitative polymer-
ase chain reaction (RT-PCR), as described by Cawthon [26].
Telomeres were measured at two points: at baseline and after 2
months of the intensive intervention period. Concentrations of
telomere repeat copy number (T) and single-copy gene (Ribosomal
Protein Large PO) copy number, (S) as a reference for each
sample, were obtained with this method.
PCRs were performed on white 384-well plates on an ABI-
Applied Biosystems 7900 HT thermal cycler (Applied Biosystems,
Austin, TX, USA). The total reaction volume was 10 mL
containing 10 ng of genomic DNA, and a quantiTect Syber
Green PCR kit (Qiagen, Valencia, CA, USA) was used as master
mix. The final telomere primer concentrations were as follows: for
telomere amplification tel1, 675 nmol/L and for tel2, 1350 nmol/
L; and for the amplification of the single copy gene RPLPO:
hRPLPO1, 800 nmol/L; hRPLPO2, 800 nmol/L. The primer
sequences (Sigma-Aldrich, St.Louis, MO, USA) were tel1 (59-
GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGG-
T-39), tel2 (59-TCCCGACTATCCCTATCCCTATCCCTATC-
CCTATCCCTA-39), hRPLPO1 (59-CCCATTCTATCATCA-
ACGGGTACAA -39) and hRPLPO2 (59-CAGCAAGTGG-
GAAGGTGTAATCC -39). This method normalizes T to S by
taking the ratio (T/S ratio) for each sample. The T/S ratio was
calculated as follows [2CT(telomeres)/2CT(single copy gene)] = 22DCT,
since the amount of the PCR product approximately doubles in
each cycle of the PCR [26].
A calibration curve of the same DNA sample of reference (64–
0.25 ng in 2-fold dilutions) was included for each measurement as
a standard, to control the day-to-day variations. Standard curve
with linearity R2.0.98 was accepted. For quality control, all
samples were run in triplicate and checked for concordance
between triplicate values. Moreover the two DNA samples of each
patient (at baseline and after 2 months of recruitment) were run in
Figure 1. Telomere length distribution in boys and girls before and after the intensive lifestyle intervention. Significant differences
were found after 2 months vs. before the multidisciplinary program.
doi:10.1371/journal.pone.0089828.g001
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the same plate. In order to obtain a robust consistence, samples
showing a high variation (more than 10%) were rerun and
reanalyzed. The intra-assay coefficient of variation between
triplicates was 1.6% and the inter-assay coefficient of variation
between plates was 3.8%, which supports the power of this
procedure.
Statistical Analysis
The sample size calculation led to conclude that at least 22
subjects were needed. This estimate was based on the following
assumptions: a two-tailed alpha error of 5%, a power of 90%, and
a mean (6 standard deviation) difference of 50650 in TL after the
intervention. Our study involved 74 subjects from the EVASYON
study who had DNA samples at baseline and after 2 months.
We compared the anthropometric measures of the adolescents
at baseline and during the weight loss treatment, stratifying the
sample by sex. We calculated means and SD for each variable and
assessed the statistical significance of the differences among them
with repeated-measures ANOVA. We used the unpaired t-test for
comparing the parameters at baseline between boys and girls.
TL was ln-transformed to achieve a better normal distribution
conformation. A paired t-test was performed to evaluate the
increase in TL after 2 months of the intensive intervention period,
dividing the participants by sex. In addition, we also calculated the
Pearson correlation coefficient (r) between baseline TL and the
change in TL after the intensive treatment period after adjusting
for age and sex.
We fitted multivariable linear regression modeling to analyze
changes in the anthropometric variables according to the increase
of 1 SD in baseline TL. Comparisons were done separately for
girls and boys and were adjusted for age, baseline BMI-SDS and
for each basal anthropometric variable depending on the analysis.
Moreover, we also assessed differences in the adiposity traits after
2 and 6 months in males, according to the median of baseline TL.
B coefficients and 95% confidence intervals (CI) were calculated
using those who had the shortest telomeres at baseline as the
reference group and multiple testing correction (Benjamini-
Hochberg) was used to control the overall two-sided alpha level
at 0.05.
Statistical analyses were performed using STATA version 12.0
(StataCorp, College Station, TX, USA). The significance level for
all the analyses was set at a= 0.05 and all the tests were two-sided.
Results
Table 1 summarizes the general features of the 74 overweight/
obese adolescents (mean age 14.361.0 yr, 49% males) at baseline
and after 2 and 6 months of the weight loss program, dividing the
population by sex. Sex differences were found at baseline
regarding abdominal obesity (p,0.050). Both males and females
did significantly lose body weight (p,0.001) after the intervention,
which was accompanied by a significant improvement in the
anthropometric measurements.
Average TL was ascertained in 74 subjects using RT-PCR. The
analyses were carried out after ln-transformed of all T/S ratios.
Interestingly, TL significantly increased after the intensive lifestyle
intervention in 88% of the adolescents (+1.93 [1.6922.18], p,
0.001) (data not shown). In this sense, mean differences values
(95% CI) were +1.66 (1.2722.06) for boys and +1.64 (1.2222.06)
among girls (Figure 1). No differences in TL were found at baseline
or during the 2 months of intensive intervention period in subjects
according to sex.
Furthermore, the individual change in TL was inversely
correlated with initial TL at a highly significant level after
controlling for age and sex (r =20.962, p,0.001; Figure 2),
indicating that the lengthening rate was most pronounced in
individuals with shorter telomeres at baseline. Due to this strong
correlation, baseline TL was considered as a potential predictor
factor for changes in adiposity in obese adolescents. Surprisingly,
we did not observe a significant association between TL and
participant’s age (r =20.122, p = 0.301; data not shown).
We fitted a multiple regression model to predict the changes in
anthropometric and adiposity traits at follow-up according to sex
(Table 2). In boys, during 2 months of the intensive treatment
phase, higher baseline TL significantly predicted a greater
Figure 2. Telomere length change after the intensive intervention as a function of telomere length at baseline. The scatter plot shows
the entire adolescent’s sample (n = 74), each dot representing one individual. Relative telomere length is adjusted for age and sex.
doi:10.1371/journal.pone.0089828.g002
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Table 2. Changes in anthropometric variables after 2 and 6 months of the weight loss program, according to the increase of 1 SD
in baseline TL.
Baseline TL
Boys (n =36) Girls (n = 38)
2 months 6 months 2 months 6 months
B (95% CI) P-value B (95% CI) P-value B (95% CI) P-value B (95% CI) P-value
D Body Weight (kg)
Unadjusted 21.35 0.017 22.08 0.086 0.44 0.487 0.27 0.767
(22.45 to 20.25) (24.48 to 0.31) (20.84 to 1.73) (21.59 to 2.13)
Adjusted1 21.53 0.005* 22.25 0.047 0.84 0.149 0.71 0.406
(25.57 to 20.49) (24.48 to 20.03) (20.32 to 2.01) 2(1.01 to 2.43)
D BMI-SDS
Unadjusted 20.20 0.014 20.46 0.006 0.10 0.484 0.03 0.780
(20.35 to 20.04) (20.78 to 20.14) (20.18 to 0.38) (20.22 to 0.29)
Adjusted1 20.22 0.010* 20.47 0.005* 0.20 0.102 0.09 0.443
(20.38 to 20.05) (20.79 to 20.15) (20.04 to 0.43) (20.15 to 0.34)
D Body fat (%)
Unadjusted 0.20 0.750 20.45 0.686 0.99 0.246 0.98 0.252
(21.08 to 1.49) (22.68 to 1.79) (20.71 to 2.69) (20.72 to 2.68)
Adjusted1 0.14 0.826 20.75 0.482 1.15 0.152 0.95 0.146
(21.13 to 1.41) (22.91 to 1.41) (20.45 to 2.75) (20.35 to 2.25)
D Waist circumference (cm)
Unadjusted 21.98 0.037 21.85 0.257 0.74 0.577 2.04 0.191
(23.48 to 20.12) (25.12 to 1.41) (21.94 to 3.42) (21.06 to 5.14)
Adjusted1 21.47 0.065 21.56 0.304 1.38 0.221 2.73 0.078
(23.04 to 0.09) (24.59 to 1.48) (20.87 to 3.62) (20.32 to 5.78)
D Hip
circumference (cm)
Unadjusted 20.72 0.505 0.50 0.725 3.86 0.125 4.70 0.067
(22.88 to 1.45) (22.38 to 3.38) (21.12 to 8.85) (20.35 to 9.74)
Adjusted1 21.83 0.065 20.92 0.409 2.52 0.260 1.58 0.493
(23.78 to 0.12) (23.17 to 1.33) (21.96 to 6.99) (23.05 to 6.21)
D Waist to hip
Unadjusted 20.01 0.461 20.04 0.021 20.05 0.103 20.09 0.051
(20.05 to 0.02) (20.09 to 20.01) (20.11 to 0.01) (20.18 to 0.01)
Adjusted1 0.01 0.914 20.03 0.084 20.04 0.209 20.05 0.309
(20.03 to 0.04) (20.07 to 0.01) (20.09 to 0.02) (20.14 to 0.04)
D Waist to height
Unadjusted 20.01 0.046 20.01 0.245 0.005 0.499 0.01 0.220
(20.02 to 20.001) (20.03 to 0.01) (20.01 to 0.02) (20.01 to 0.03)
Adjusted1 20.01 0.078 20.01 0.251 0.01 0.117 0.01 0.119
(20.02 to 0.001) (20.03 to 0.01) (20.01 to 0.02) (20.01 to 0.03)
D S 6 skinfolds (mm)
Unadjusted 22.92 0.306 24.08 0.347 4.04 0.300 7.37 0.220
(28.63 to 2.79) (212.77 to 4.61) (23.75 to 11.83) (20.71 to 15.46)
Adjusted1 22.18 0.440 23.79 0.411 4.41 0.237 7.48 0.059
(27.87 to 3.51) (213.06 to 5.48) (23.04 to 11.87) (20.30 to 15.25)
TL: telomere length, BMI-SDS: Standard Deviation Score for BMI, SD: Standard Deviation.
1Adjusted for age, basal BMI-SDS and the respective variable at baseline.
*P-value ,0.05 after correcting for Benjamini–Hochberg multiple comparisons.
doi:10.1371/journal.pone.0089828.t002
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reduction in body weight (B =21.53, 95% CI: 25.57 to 20.49)
and BMI-SDS (B =20.22, 95% CI: 20.38 to 20.05) after
adjusting for age and the respective variable at baseline. Moreover,
a discernible trend was observed in waist circumference (B =
21.47, 95% CI:23.04 to 0.09), hip circumference (B =21.83,
95% CI:23.78 to 0.12), and waist to height ratio (B =20.01, 95%
CI:20.02 to 0.001). However, no differences were observed in
girls. Interestingly, males with higher initial TL also presented a
greater decrease in body weight (B =22.25, 95% CI:24.48 to
20.03) and BMI-SDS (B =20.47, 95% CI:20.79 to 20.15) after
6 months of the multidisciplinary intervention.
In addition, when we dichotomized the male sample at the
median of baseline TL, those who presented longer telomeres
displayed a greater reduction in body weight (p = 0.001), BMI-
SDS (p = 0.004) and hip circumference (p = 0.012), and they
showed a similar trend in waist circumference (p = 0.067), and
waist to height ratio (p = 0.061) after the intensive lifestyle program
(Table 3). Similarly, after 6 months of the intervention, the longer
the initial TL, the higher the decrease in body weight (p = 0.014)
and BMI-SDS (p = 0.002).
Discussion
In this study encompassing 74 overweight/obese adolescents, a
significant increase in TL after 2 months of a multidisciplinary
program was found. Interestingly, we observed a significant
association between baseline TL and changes in adiposity traits in
boys which remained significant after 6 months of follow-up. To
our knowledge, this study assessed for the first time the relationship
between TL and changes in obesity traits in an obese adolescent
population.
We did not observe differences in TL according to age or sex, in
agreement with studies in children and adolescent populations
[15,16]. The narrow age range of our adolescent population (12–
16 years) and the relatively small sample size did not favor this age-
related phenomenon.
Interestingly, we showed that an integral intervention for weight
loss may contribute to the prevention of telomere shortening. In
adults, a 4-month supplementation with omega-3 did increase
leukocyte TL [27]. In other cell types an increase in TL was
observed after 1 or 3 months dietary intervention in adult subjects
[18,28]. Two potential mechanisms could explain this telomere
lengthening: a reduction in biochemical stress or a replenishment
of younger cells with longer telomeres into circulation [29].
However, our findings need to be further explored in other
populations to better understand this biological mechanism.
Besides, subjects who had the shortest telomeres at baseline
presented the greatest increase in TL that is in concordance with
other adult studies [30–32]. This finding might be due to TL
maintenance machinery which is focused on protecting the
Table 3. Multivariable-adjusted differences (95% confidence intervals) in the change of the anthropometric measures, by the
median of baseline telomere length in boys.
Baseline TL
,2.34 $2.34 P-value
(n=18) (n =18)
Change in obesity traits
Body weight (kg)
2 months 22.85 (24.21 to 21.49) 26.54 (27.89 to 25.18) 0.001*
6 months 23.99 (27.04 to 20.95) 29.67 (212.62 to 26.71) 0.014*
BMI-SDS
2 months 20.68 (20.89 to 20.46) 21.16 (21.38 to 20.95) 0.004*
6 months 21.06 (21.51 to 20.62) 22.12 (22.55 to 21.69) 0.002*
Waist circumference (cm)
2 months 21.97 (24.08 to 0.23) 24.89 (27.05 to 22.74) 0.067
6 months 28.79 (212.99 to 4.59) 211.23 (215.43 to 27.03) 0.429
Hip circumference (cm)
2 months 20.20 (22.70 to 2.29) 25.10 (27.60 to 22.60) 0.012*
6 months 25.56 (28.57 to 22.54) 27.51 (210.53 to 24.50) 0.388
Waist to hip ratio
2 months 20.03 (20.08 to 0.02) 20.01 (20.05 to 0.04) 0.450
6 months 20.03 (20.08 to 0.02) 20.07(20.12 to 20.02) 0.262
Waist to height ratio
2 months 20.01 (20.03 to 20.001) 20.03 (20.05 to 20.02) 0.061
6 months 20.06 (20.09 to 20.04) 20.08 (20.10 to 20.06) 0.326
S 6 skinfolds (mm)
2 months 214.07 (221.90 to26.25) 218.62 (226.45 to 210.80) 0.429
6 months 228.85 (241.59 to 216.10) 236.60 (249.35 to 223.86) 0.408
Data is presented as B (95%CI). TL: telomere length, BMI-SDS: Standard Deviation Score for BMI.
Adjusted for age, basal BMI-SDS and the respective variable at baseline.
*P-value ,0.05 after correcting for Benjamini–Hochberg multiple comparisons.
doi:10.1371/journal.pone.0089828.t003
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shortest telomeres [33–35]. It could be speculated that obese
adolescents with longer telomeres at baseline had a lower rate of
telomere lengthening, since the change in TL mainly depends on
the initial TL, achieving a greater weight loss.
Few epidemiologic studies have investigated the association of
TL and obesity traits in young population [14–17]. In adolescents
a cross-sectional study did not observe association between TL and
adiposity indices [17]. Obese children (French and Arab) showed
shorter telomeres than their nonobese counterparts [15,16]. In
Italian children no difference in TL between obese and nonobese
children was found [14]. However, our findings give valuable
information in a longitudinal way.
This study proposed TL as a biomarker for adiposity changes,
as we showed that the longer the initial telomere, the greater the
decrease in obesity parameters. In this regard, Njajou et al. [9]
observed TL to be significantly associated with percentage of
change in BMI and in body fat during a 7-year follow-up in the
elderly. In the frame of the PREDIMED study, we recently
reported that higher initial TL could predict a greater decrease in
obesity anthropometric variables in an elderly population [11].
Furthermore, significant associations between TL and changes
in adiposity indices were observed only in boys. The sex effect
elicited in this study confirms the findings of Al-Attas et al. who
observed a relationship between obesity and TL in boys aged 5–12
years [15]. Nevertheless, the possible explanation for our sex
difference might be due to biological sex differences that may
modulate this association. In fact, our participants were at a high
growing rate where hormones, particularly in girls, could play an
important role.
Some limitations should be acknowledged. There is a debate on
whether observed telomere lengthening is real or an artifact
caused by measurement errors. Thus, Steenstrup et al. [36] showed
that the effect of measurement error can be reduced in
longitudinal studies by presenting meticulous attention to potential
measurement problems. Therefore, we have carefully controlled
the experimental conditions to avoid potential errors: genomic
DNA was processed following a standardized protocol to preserve
its stability; and also the two DNA samples per patient (at baseline
and after 2 months) were run in the same plate. Nevertheless, it
should be recognised that our study consisted in a short
intervention period leading to the possibility of individuals to be
misclassified as TL gainers [36]. The small sample size and the
progressive pubertal stages among participants are also weaknesses
of this study. However, the fact that important statistical
differences were found suggests that potential type-II errors were
overcome. On the other hand, strengths of our study include: 1)
the design allows reproducing real-time conditions with home-
prepared foods in free-living individuals, as in usual clinical
practice; 2) measurements in young subjects are not confounded
by chronic obesity-related disorders.
In conclusion, our results suggest that a multidisciplinary
intervention in obese adolescents did achieve not only weight
loss, but an increase in TL. Moreover, we show that initial longer
telomeres could predict a better weight loss response to a
multidisciplinary intervention program in overweight/obese male
adolescents. However, further larger longitudinal studies are
warranted to confirm these results and better understand this
complicated association, especially at a young age in order to
prevent adult obesity-related complications.
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